Skip to main content
. 2017 Apr 12;12(4):e0175529. doi: 10.1371/journal.pone.0175529

Table 1. Baseline patient characteristics: Comparison of MARS and standard medical treatment (SMT).

Laboratory Parameter MARS (n = 32) SMT (n = 41) p-value
Age (years) mean (SD) 48.9 (17.8) 49.4 (16.0) 0.925
range 18–76 21–85
Male sex, n (%) 20 (62.5) 23 (56.1) 0.581
Body weight (kg), mean (SD) 82.1 (18.1) 75.9 (21.5) 0.146
Etiology of liver disease, n (%) Paracetamol 2 (6.2) 1 (2.4)
Non-paracetamol 20 (62.5) 30 (73.2)
Viral 1 7
Autoimmune 0 9
Drug-induced 15 12
Mushroom poisoning/toxin 0 0
Unknown/other 4 2
Graft dysfunction 10 (31.3) 10 (24.4)
Rejection 5 2
Biliary casts 2 3
Unknown/other 3 5
Hepatic encephalopathy, n (%) Grade ≤1 32 (100) 38 (92.7) 0.417
Grade 2–3 0 3 (7.3)
Mechanical ventilation, n 0 0 n.a.
MAP (mmHg) 97.6 (11.5) 98.6 (14.8) 0.804
Vasopressors, n 0 0 n.a.
Heart rate (bpm) 75.9 (8.6) 82.3 (14.9) 0.206
Laboratory data, mean (SD) Total bilirubin (mg/dL) 18.8 (9.3) 14.9 (8.0) 0.037
AST (U/L) 570.5 (721.2) 1079.1 (915.1) 0.011
ALT (U/L) 826.7 (703.7) 1414.5 (1298.4) 0.058
Serum sodium (mEq/L) 136.5 (3.8) 138.2 (3.8) 0.127
Serum potassium (mEq/L) 4.0 (4.9) 3.9 (0.5) 0.333
Creatinine (mg/dL) 1.2 (0.6) 1.3 (1.2) 0.740
BUN (mg/dL) 24.8 (18.1) 20.0 (13.9) 0.235
White blood count (103 cells/μL) 7.7 (3.3) 7.2 (2.96) 0.687
Hemoglobin (g/dL) 11.9 (2.2) 12.8 (2.8) 0.055
Platelets (103 cells/μL) 229.8 (109.9) 182.4 (92.8) 0.074
Albumin (g/dL) 3.4 (0.5) 3.2 (0.5) 0.768
Prothrombin level (Quick) (%) 72.9 (26.8) 56.4 (20.5) 0.012
INR 1.3 (0.3) 1.5 (0.5) 0.015
MELD Score, mean (SD) 20.6 (7.1) 22.5 (4.8) 0.555

Abbr.: MAP: Mean arterial pressure; BUN: blood urea nitrogen; INR: international normalized ratio; MELD: model of end-stage liver disease; SD: standard deviation; AST: aspartate transaminase; ALT: alanine transaminase